[go: up one dir, main page]

NO993076D0 - Process for crystallizing a tetrahydropyridine derivative and resulting crystalline forms - Google Patents

Process for crystallizing a tetrahydropyridine derivative and resulting crystalline forms

Info

Publication number
NO993076D0
NO993076D0 NO993076A NO993076A NO993076D0 NO 993076 D0 NO993076 D0 NO 993076D0 NO 993076 A NO993076 A NO 993076A NO 993076 A NO993076 A NO 993076A NO 993076 D0 NO993076 D0 NO 993076D0
Authority
NO
Norway
Prior art keywords
crystallizing
crystalline forms
resulting crystalline
tetrahydropyridine derivative
tetrahydropyridine
Prior art date
Application number
NO993076A
Other languages
Norwegian (no)
Other versions
NO993076L (en
NO312364B1 (en
Inventor
Antoine Caron
Bruno Franc
Olivier Monnier
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO993076L publication Critical patent/NO993076L/en
Publication of NO993076D0 publication Critical patent/NO993076D0/en
Publication of NO312364B1 publication Critical patent/NO312364B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19993076A 1996-12-23 1999-06-22 Process for crystallizing a tetrahydropyridine derivative and resulting crystalline forms NO312364B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615904A FR2757543B1 (en) 1996-12-23 1996-12-23 PROCESS FOR THE CRYSTALLIZATION OF A TETRAHYDROPYRIDINE DERIVATIVE AND CRYSTALLINE FORMS THUS OBTAINED
PCT/FR1997/002393 WO1998028271A1 (en) 1996-12-23 1997-12-23 Method for the crystallisation of a tetrahydopyridin derivative and resulting crystalline forms

Publications (3)

Publication Number Publication Date
NO993076L NO993076L (en) 1999-06-22
NO993076D0 true NO993076D0 (en) 1999-06-22
NO312364B1 NO312364B1 (en) 2002-04-29

Family

ID=9499043

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993076A NO312364B1 (en) 1996-12-23 1999-06-22 Process for crystallizing a tetrahydropyridine derivative and resulting crystalline forms

Country Status (38)

Country Link
EP (1) EP0950050B1 (en)
JP (2) JP4499188B2 (en)
KR (1) KR100586670B1 (en)
CN (1) CN1129580C (en)
AR (1) AR009672A1 (en)
AT (1) ATE307802T1 (en)
AU (1) AU736697B2 (en)
BR (1) BR9714081A (en)
CA (1) CA2275596C (en)
CO (1) CO5070688A1 (en)
CZ (1) CZ296689B6 (en)
DE (1) DE69734460T2 (en)
DK (1) DK0950050T3 (en)
DZ (1) DZ2383A1 (en)
EE (1) EE04188B1 (en)
EG (1) EG21567A (en)
ES (1) ES2251038T3 (en)
FR (1) FR2757543B1 (en)
HR (1) HRP970699B1 (en)
HU (1) HU227425B1 (en)
IL (1) IL129938A (en)
IN (1) IN186976B (en)
IS (1) IS2357B (en)
MY (1) MY118015A (en)
NO (1) NO312364B1 (en)
NZ (1) NZ336130A (en)
PL (1) PL190494B1 (en)
RS (1) RS49882B (en)
RU (1) RU2192416C2 (en)
SA (1) SA98180971B1 (en)
SI (1) SI0950050T1 (en)
SK (1) SK285088B6 (en)
TR (1) TR199901363T2 (en)
TW (1) TW518322B (en)
UA (1) UA60324C2 (en)
UY (1) UY24825A1 (en)
WO (1) WO1998028271A1 (en)
ZA (1) ZA9711576B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757543B1 (en) * 1996-12-23 1999-04-02 Sanofi Sa PROCESS FOR THE CRYSTALLIZATION OF A TETRAHYDROPYRIDINE DERIVATIVE AND CRYSTALLINE FORMS THUS OBTAINED
FR2782082B3 (en) * 1998-08-05 2000-09-22 Sanofi Sa CRYSTALLINE FORMS OF (R) - (+) - N - [[3- [1-BENZOYL-3- (3,4- DICHLOROPHENYL) PIPERIDIN-3-YL] PROP-1-YL] -4-PHENYLPIPERIDIN-4 - YL] -N-METHYLACETAMIDE (OSANETANT) AND PROCESS FOR THE PREPARATION OF SAID COMPOUND
WO2011111856A1 (en) 2010-03-12 2011-09-15 株式会社日本触媒 Method for manufacturing a water-absorbing resin
JP5870183B2 (en) * 2011-04-15 2016-02-24 エムキュア ファーマシューティカルズ リミテッド Method for the synthesis of rilpivirine intermediate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531707A1 (en) * 1982-08-16 1984-02-17 Midy Spa SUBSTITUTED TRIFLUOROMETHYLPHENYLTETRAHYDROPYRIDINES WITH ANOREXIGENIC ACTIVITY, A PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS
FR2757543B1 (en) * 1996-12-23 1999-04-02 Sanofi Sa PROCESS FOR THE CRYSTALLIZATION OF A TETRAHYDROPYRIDINE DERIVATIVE AND CRYSTALLINE FORMS THUS OBTAINED

Also Published As

Publication number Publication date
TW518322B (en) 2003-01-21
SK82899A3 (en) 1999-12-10
PL190494B1 (en) 2005-12-30
CA2275596A1 (en) 1998-07-02
IS5076A (en) 1999-06-10
WO1998028271A1 (en) 1998-07-02
ZA9711576B (en) 1998-06-25
DK0950050T3 (en) 2006-01-23
PL334256A1 (en) 2000-02-14
CN1129580C (en) 2003-12-03
IN186976B (en) 2001-12-22
CZ229299A3 (en) 1999-09-15
KR20000069504A (en) 2000-11-25
UY24825A1 (en) 1998-04-21
RU2192416C2 (en) 2002-11-10
NO993076L (en) 1999-06-22
CO5070688A1 (en) 2001-08-28
HU227425B1 (en) 2011-05-30
YU28999A (en) 2003-01-31
ATE307802T1 (en) 2005-11-15
NO312364B1 (en) 2002-04-29
CZ296689B6 (en) 2006-05-17
RS49882B (en) 2008-08-07
DE69734460D1 (en) 2005-12-01
HRP970699B1 (en) 2007-03-31
EG21567A (en) 2001-12-31
FR2757543A1 (en) 1998-06-26
ES2251038T3 (en) 2006-04-16
HRP970699A2 (en) 1998-10-31
EE04188B1 (en) 2003-12-15
TR199901363T2 (en) 1999-08-23
EP0950050B1 (en) 2005-10-26
CN1241180A (en) 2000-01-12
UA60324C2 (en) 2003-10-15
JP2001507012A (en) 2001-05-29
AU736697B2 (en) 2001-08-02
DE69734460T2 (en) 2006-07-06
IL129938A (en) 2004-06-20
EE9900264A (en) 2000-02-15
IS2357B (en) 2008-04-15
FR2757543B1 (en) 1999-04-02
JP2009197022A (en) 2009-09-03
IL129938A0 (en) 2000-02-29
AR009672A1 (en) 2000-04-26
JP4499188B2 (en) 2010-07-07
HK1024002A1 (en) 2000-09-29
HUP0001387A2 (en) 2000-09-28
SI0950050T1 (en) 2006-04-30
AU5668498A (en) 1998-07-17
SK285088B6 (en) 2006-06-01
CA2275596C (en) 2005-10-11
EP0950050A1 (en) 1999-10-20
MY118015A (en) 2004-08-30
KR100586670B1 (en) 2006-06-07
DZ2383A1 (en) 2002-12-28
NZ336130A (en) 2001-01-26
SA98180971B1 (en) 2006-09-13
BR9714081A (en) 2000-05-09
HUP0001387A3 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
ZA962200B (en) Piperidine derivatives
FI956270L (en) Piperidine derivatives and method for their preparation
NO180484C (en) Process for preparing substituted piperidines
HUP9903454A3 (en) A crystalline form of cefditoren pivoxyl and process for the production of the same
NO993006D0 (en) A process for separating the paraxyl comprising an adsorption step with water injection and a crystallization step
FI933391A7 (en) Triazolylthiomethylthio-cephalosporin hydrochloride, its crystallized hydrate and a process for their preparation
NO944289L (en) Method for examining a wellbore
DE69620107D1 (en) crystallization process
DK0842170T3 (en) Diphenylmethylene piperidine derivatives
IL105328A0 (en) Process for preparing piperidine derivatives
DK0734382T3 (en) Crystalline N-acetyl-neuramic acid derivatives and methods for their preparation
HU9503213D0 (en) New crystalline cepheme-acid-addicional salts and process for producing them
NO993076D0 (en) Process for crystallizing a tetrahydropyridine derivative and resulting crystalline forms
FI942288L (en) Method for making a fuse
EP1076064A4 (en) Novel aspartame derivative crystal and process for producing the same
AU7104596A (en) Piperidine derivatives and processes for their production
MD254B1 (en) Apple cultivation process
GB9516767D0 (en) Process for producing piperidine derivatives
MD940028A (en) Process for obtaining crystalline tylosin
HU9203562D0 (en) Benzoquinoxaline derivatives and method for producing them
EP1076063A4 (en) Novel aspartame derivative crystal and process for producing the same
HUP9702472A3 (en) Process for producing allyl-amine derivative and salts thereof
FI940326A0 (en) Method for making a peat product
NO963437D0 (en) Method and device for mounting a tool string
NO943062L (en) Asymmetric substituted diaminodicarboxylic acid derivatives and a process for their preparation

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees